Year in Review in Axial Spondyloarthritis Clinical Research and Guidelines: SPARTAN 2023 Annual Meeting Proceedings
Purpose of Review To highlight high impact clinical publications in spondyloarthritis from May 2022 to April 2023 that were summarized and presented at the SPARTAN annual meeting in May 2023. Recent Findings Publications included updated guidelines on management of axial spondyloarthritis (axSpA) by...
Gespeichert in:
| Veröffentlicht in: | Current rheumatology reports 2024-05, Vol.26 (5), p.164-169 |
|---|---|
| 1. Verfasser: | |
| Format: | Artikel |
| Sprache: | eng |
| Schlagworte: | |
| Online-Zugang: | Volltext |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | 169 |
|---|---|
| container_issue | 5 |
| container_start_page | 164 |
| container_title | Current rheumatology reports |
| container_volume | 26 |
| creator | Dubreuil, Maureen |
| description | Purpose of Review
To highlight high impact clinical publications in spondyloarthritis from May 2022 to April 2023 that were summarized and presented at the SPARTAN annual meeting in May 2023.
Recent Findings
Publications included updated guidelines on management of axial spondyloarthritis (axSpA) by ASAS-EULAR and development of a modified Juvenile Spondyloarthritis Disease Activity Index (JSpADA). Definitions were published for MRI lesions of the spine in axSpA and active and structural sacroiliac (SI) joint lesions in juvenile spondyloarthritis (JSpA). Anatomic variants of the sacroiliac joint were commonly detected using synthetic CT derived from pelvis MRI images. Anti-CD74 antibodies hold promise as a diagnostic biomarker for axSpA; however, the mechanism of such antibody development seems unrelated to gastrointestinal inflammation.
Summary
High impact clinical publications in spondyloarthritis addressed lab-based and imaging biomarkers, outcome measures, and updated management guidelines. |
| doi_str_mv | 10.1007/s11926-024-01134-z |
| format | Article |
| fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_2925000110</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>2925000110</sourcerecordid><originalsourceid>FETCH-LOGICAL-c298t-c6a965fc6e5ce297ff99bc101d7212d1b50472e4b98712d938faaccdce18f1953</originalsourceid><addsrcrecordid>eNp9kLlOxDAURS0EYv8BCuSSJvBsZzNdNIIBiU0DFFSWx3kBo4wz2Anb1-NhgJLK17qL9A4hewwOGUBxFBiTPE-ApwkwJtLkc4VssiyKXECxutBcJKIo0g2yFcIzAAcoxTrZEKVIgedyk4QH1J5aRyf4avFtoap3q1t6O-9c_dF22vdP3vY20FFrnTXRmmCIJfNEtavpeLA1RgfDMb29qSZ31RXlwAWtnBti-BKxt-6R3vjOINZRhh2y1ug24O7Pu03uT0_uRmfJxfX4fFRdJIbLsk9MrmWeNSbHzCCXRdNIOTUMWF1wxms2zSAtOKZTWRbxL0XZaG1MbZCVDZOZ2CYHy925714GDL2a2WCwbbXDbgiKS54BRHQQo3wZNb4LwWOj5t7OtP9QDNQCtlrCVhG2-oatPmNp_2d_mM6w_qv80o0BsQyEaLlH9Oq5G7yLN_83-wW93IqI</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2925000110</pqid></control><display><type>article</type><title>Year in Review in Axial Spondyloarthritis Clinical Research and Guidelines: SPARTAN 2023 Annual Meeting Proceedings</title><source>MEDLINE</source><source>Springer Nature - Complete Springer Journals</source><creator>Dubreuil, Maureen</creator><creatorcontrib>Dubreuil, Maureen</creatorcontrib><description>Purpose of Review
To highlight high impact clinical publications in spondyloarthritis from May 2022 to April 2023 that were summarized and presented at the SPARTAN annual meeting in May 2023.
Recent Findings
Publications included updated guidelines on management of axial spondyloarthritis (axSpA) by ASAS-EULAR and development of a modified Juvenile Spondyloarthritis Disease Activity Index (JSpADA). Definitions were published for MRI lesions of the spine in axSpA and active and structural sacroiliac (SI) joint lesions in juvenile spondyloarthritis (JSpA). Anatomic variants of the sacroiliac joint were commonly detected using synthetic CT derived from pelvis MRI images. Anti-CD74 antibodies hold promise as a diagnostic biomarker for axSpA; however, the mechanism of such antibody development seems unrelated to gastrointestinal inflammation.
Summary
High impact clinical publications in spondyloarthritis addressed lab-based and imaging biomarkers, outcome measures, and updated management guidelines.</description><identifier>ISSN: 1523-3774</identifier><identifier>EISSN: 1534-6307</identifier><identifier>DOI: 10.1007/s11926-024-01134-z</identifier><identifier>PMID: 38340269</identifier><language>eng</language><publisher>New York: Springer US</publisher><subject>Axial Spondyloarthritis - drug therapy ; Biomedical Research ; Humans ; Medicine ; Medicine & Public Health ; Practice Guidelines as Topic ; Review ; Rheumatology ; Topical Collection on Spondyloarthritis</subject><ispartof>Current rheumatology reports, 2024-05, Vol.26 (5), p.164-169</ispartof><rights>This is a U.S. Government work and not under copyright protection in the US; foreign copyright protection may apply 2024</rights><rights>2024. This is a U.S. Government work and not under copyright protection in the US; foreign copyright protection may apply.</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><cites>FETCH-LOGICAL-c298t-c6a965fc6e5ce297ff99bc101d7212d1b50472e4b98712d938faaccdce18f1953</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://link.springer.com/content/pdf/10.1007/s11926-024-01134-z$$EPDF$$P50$$Gspringer$$H</linktopdf><linktohtml>$$Uhttps://link.springer.com/10.1007/s11926-024-01134-z$$EHTML$$P50$$Gspringer$$H</linktohtml><link.rule.ids>314,776,780,27903,27904,41467,42536,51298</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/38340269$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Dubreuil, Maureen</creatorcontrib><title>Year in Review in Axial Spondyloarthritis Clinical Research and Guidelines: SPARTAN 2023 Annual Meeting Proceedings</title><title>Current rheumatology reports</title><addtitle>Curr Rheumatol Rep</addtitle><addtitle>Curr Rheumatol Rep</addtitle><description>Purpose of Review
To highlight high impact clinical publications in spondyloarthritis from May 2022 to April 2023 that were summarized and presented at the SPARTAN annual meeting in May 2023.
Recent Findings
Publications included updated guidelines on management of axial spondyloarthritis (axSpA) by ASAS-EULAR and development of a modified Juvenile Spondyloarthritis Disease Activity Index (JSpADA). Definitions were published for MRI lesions of the spine in axSpA and active and structural sacroiliac (SI) joint lesions in juvenile spondyloarthritis (JSpA). Anatomic variants of the sacroiliac joint were commonly detected using synthetic CT derived from pelvis MRI images. Anti-CD74 antibodies hold promise as a diagnostic biomarker for axSpA; however, the mechanism of such antibody development seems unrelated to gastrointestinal inflammation.
Summary
High impact clinical publications in spondyloarthritis addressed lab-based and imaging biomarkers, outcome measures, and updated management guidelines.</description><subject>Axial Spondyloarthritis - drug therapy</subject><subject>Biomedical Research</subject><subject>Humans</subject><subject>Medicine</subject><subject>Medicine & Public Health</subject><subject>Practice Guidelines as Topic</subject><subject>Review</subject><subject>Rheumatology</subject><subject>Topical Collection on Spondyloarthritis</subject><issn>1523-3774</issn><issn>1534-6307</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2024</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNp9kLlOxDAURS0EYv8BCuSSJvBsZzNdNIIBiU0DFFSWx3kBo4wz2Anb1-NhgJLK17qL9A4hewwOGUBxFBiTPE-ApwkwJtLkc4VssiyKXECxutBcJKIo0g2yFcIzAAcoxTrZEKVIgedyk4QH1J5aRyf4avFtoap3q1t6O-9c_dF22vdP3vY20FFrnTXRmmCIJfNEtavpeLA1RgfDMb29qSZ31RXlwAWtnBti-BKxt-6R3vjOINZRhh2y1ug24O7Pu03uT0_uRmfJxfX4fFRdJIbLsk9MrmWeNSbHzCCXRdNIOTUMWF1wxms2zSAtOKZTWRbxL0XZaG1MbZCVDZOZ2CYHy925714GDL2a2WCwbbXDbgiKS54BRHQQo3wZNb4LwWOj5t7OtP9QDNQCtlrCVhG2-oatPmNp_2d_mM6w_qv80o0BsQyEaLlH9Oq5G7yLN_83-wW93IqI</recordid><startdate>20240501</startdate><enddate>20240501</enddate><creator>Dubreuil, Maureen</creator><general>Springer US</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope></search><sort><creationdate>20240501</creationdate><title>Year in Review in Axial Spondyloarthritis Clinical Research and Guidelines: SPARTAN 2023 Annual Meeting Proceedings</title><author>Dubreuil, Maureen</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c298t-c6a965fc6e5ce297ff99bc101d7212d1b50472e4b98712d938faaccdce18f1953</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2024</creationdate><topic>Axial Spondyloarthritis - drug therapy</topic><topic>Biomedical Research</topic><topic>Humans</topic><topic>Medicine</topic><topic>Medicine & Public Health</topic><topic>Practice Guidelines as Topic</topic><topic>Review</topic><topic>Rheumatology</topic><topic>Topical Collection on Spondyloarthritis</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Dubreuil, Maureen</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>Current rheumatology reports</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Dubreuil, Maureen</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Year in Review in Axial Spondyloarthritis Clinical Research and Guidelines: SPARTAN 2023 Annual Meeting Proceedings</atitle><jtitle>Current rheumatology reports</jtitle><stitle>Curr Rheumatol Rep</stitle><addtitle>Curr Rheumatol Rep</addtitle><date>2024-05-01</date><risdate>2024</risdate><volume>26</volume><issue>5</issue><spage>164</spage><epage>169</epage><pages>164-169</pages><issn>1523-3774</issn><eissn>1534-6307</eissn><abstract>Purpose of Review
To highlight high impact clinical publications in spondyloarthritis from May 2022 to April 2023 that were summarized and presented at the SPARTAN annual meeting in May 2023.
Recent Findings
Publications included updated guidelines on management of axial spondyloarthritis (axSpA) by ASAS-EULAR and development of a modified Juvenile Spondyloarthritis Disease Activity Index (JSpADA). Definitions were published for MRI lesions of the spine in axSpA and active and structural sacroiliac (SI) joint lesions in juvenile spondyloarthritis (JSpA). Anatomic variants of the sacroiliac joint were commonly detected using synthetic CT derived from pelvis MRI images. Anti-CD74 antibodies hold promise as a diagnostic biomarker for axSpA; however, the mechanism of such antibody development seems unrelated to gastrointestinal inflammation.
Summary
High impact clinical publications in spondyloarthritis addressed lab-based and imaging biomarkers, outcome measures, and updated management guidelines.</abstract><cop>New York</cop><pub>Springer US</pub><pmid>38340269</pmid><doi>10.1007/s11926-024-01134-z</doi><tpages>6</tpages></addata></record> |
| fulltext | fulltext |
| identifier | ISSN: 1523-3774 |
| ispartof | Current rheumatology reports, 2024-05, Vol.26 (5), p.164-169 |
| issn | 1523-3774 1534-6307 |
| language | eng |
| recordid | cdi_proquest_miscellaneous_2925000110 |
| source | MEDLINE; Springer Nature - Complete Springer Journals |
| subjects | Axial Spondyloarthritis - drug therapy Biomedical Research Humans Medicine Medicine & Public Health Practice Guidelines as Topic Review Rheumatology Topical Collection on Spondyloarthritis |
| title | Year in Review in Axial Spondyloarthritis Clinical Research and Guidelines: SPARTAN 2023 Annual Meeting Proceedings |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-23T01%3A55%3A36IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Year%20in%20Review%20in%20Axial%20Spondyloarthritis%20Clinical%20Research%20and%20Guidelines:%20SPARTAN%202023%20Annual%20Meeting%20Proceedings&rft.jtitle=Current%20rheumatology%20reports&rft.au=Dubreuil,%20Maureen&rft.date=2024-05-01&rft.volume=26&rft.issue=5&rft.spage=164&rft.epage=169&rft.pages=164-169&rft.issn=1523-3774&rft.eissn=1534-6307&rft_id=info:doi/10.1007/s11926-024-01134-z&rft_dat=%3Cproquest_cross%3E2925000110%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=2925000110&rft_id=info:pmid/38340269&rfr_iscdi=true |